Single-Cell Cloning Remains a Challenge
Evolving Technologies Help Make It Easier to Meet Regulatory Requirements
Blood Protein Linked to Mental Disorders
Consciousness-Aiding Protein Produced by Cells Deep in the Brainstem
Cannabinoid-Based Drugs Seek New High, Part II
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Organs-on-Chips Take Flight
Initiative to Use Technology Aboard International Space Station Set to Begin
Marc Semigran M.D.
Marc Semigran, M.D., is the chief medical officer for MyoKardia. Previously, he led the Massachusetts General Hospital Heart Failure and Cardiac Transplant Program as section head and medical director. Dr. Semigran was a member of the internal medicine and cardiology staff of Massachusetts General for more than 25 years and is an associate professor at Harvard Medical School, where he also earned his A.B., A.M. and M.D. degrees.
More GEN Content From This Contributor
- GEN Exclusives: Why Cardiology Is Ripe to Become the Next Frontier for Precision Medicine
- Feature Articles: Why Cardiology Is the Next Frontier for Precision Medicine